Cellectar Biosciences, Inc.
CLRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12,554 | $11,041 | $13,905 | $23,289 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | -$0 | -$0 | $987 | $962 |
| Total Curr. Assets | $13,622 | $12,618 | $14,893 | $24,250 |
| Property Plant & Equip (Net) | $976 | $1,048 | $1,120 | $1,194 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $30 | $30 | $30 | $30 |
| Total NC Assets | $1,006 | $1,078 | $1,150 | $1,224 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,628 | $13,695 | $16,042 | $25,474 |
| Liabilities | – | – | – | – |
| Payables | $4,015 | $4,679 | $3,874 | $4,105 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $802 | $1,096 | $2,058 | $4,587 |
| Total Curr. Liab. | $4,912 | $5,867 | $6,021 | $9,388 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1,382 | $1,382 |
| Total NC Liab. | $336 | $361 | $1,768 | $1,792 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $432 | $454 | $474 | $494 |
| Total Liabilities | $5,248 | $6,228 | $7,789 | $11,179 |
| Equity | – | – | – | – |
| Pref Stock | $1,903 | $1,903 | $521 | $521 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$263,838 | -$259,394 | -$253,946 | -$247,342 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $9,379 | $7,467 | $8,253 | $14,295 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,628 | $13,695 | $16,042 | $25,474 |
| Net Debt | -$12,554 | -$11,041 | -$13,905 | -$23,289 |